Eosinophilic Gastroenteritis Complicating Perforation in a Hepatitis C Patient Treated with Direct-Acting Antivirals

Ming X Huang, Chun N Li, Ruo M Ke, Zuo Q Zhang, Zhe Zhu and Xiao M Peng

Department of Infectious Diseases, Sun Yat-Sen University, China Department of Radiology, Sun Yat-Sen University, China Department of Medicine, University of California, USA Central Laboratory, Sun Yat-Sen University, China

^*Correspondance to: Xiao M Peng 

 PDF  Full Text Case Study | Open Access

Abstract:

The Direct-Acting Antiviral (DAA) therapy of Hepatitis C Virus (HCV) infection has demonstrated excellent efficacy and safety profile. Based on large cohort studies, Serious Adverse Events (SAEs) are rare [1,2]. Here, we reported the first case of a patient with alcoholic liver cirrhosis super infected by HCV presenting with a SAE of Eosinophilic Gastro Enteritis (EGE) complicating acute perforation during daclatasvir plus sofosbuvir therapy

Keywords:

CT: Computed Tomography; DAA: Direct-Acting Antiviral; EGE: Eosinophilic Gastro Enteritis; HCV: Hepatitis C Virus; SAE: Serious Adverse Event

Cite the Article:

Huang MX, Li CN, Ke RM, Zhang ZQ, Zhu Z, Peng XM. Eosinophilic Gastroenteritis Complicating Perforation in a Hepatitis C Patient Treated with Direct-Acting Antivirals. Clin Case Rep Int. 2020; 4: 1140.